China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- 6 drown in incident at North China mining plant
- SCO unites on green growth, cultural bonds
- China plans to venture farther into deep space
- SCO delegates gather in Tianjin for the 2025 Inter-Civilizational Dialogue
- China charts low-carbon path for energy sector
- Crew of Shenzhou XIX mission awarded for service
